Improving outcomes through the use of surgical sealants for anastomotic sealing during cardiovascular surgery: Review articles

Abelardo DeAnda, John A. Elefteriades, Nahidh W. Hasaniya, Omar M. Lattouf, Robert R. Lazzara

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The continued need to minimize blood product usage both during and after cardiac surgical procedures has been challenged by a changing patient population, and most recently by the withdrawal of the antifibrinolytic aprotinin (Trasylol, Bayer Pharmaceuticals, West Haven, CT, USA) from the market. To meet these challenges, a variety of topical hemostatic tools have continued to emerge in the surgical armamentarium. These include hemostatic agents, adhesives, and sealants designed to control perioperative bleeding and decrease blood product utilization. Optimal application of novel topical adjuncts can be limited due to the lack of clarity on how to differentiate between these adjunctive hemostatic products and their appropriate uses. This paper will review the classes of these products, how and where such products can be used during cardiovascular surgery for achieving hemostasis, and the potential for improved outcomes through the appropriate selection and use of these agents.

Original languageEnglish (US)
Pages (from-to)325-333
Number of pages9
JournalJournal of Cardiac Surgery
Volume24
Issue number3
DOIs
StatePublished - May 2009
Externally publishedYes

Fingerprint

Hemostatics
Aprotinin
Cardiac Surgical Procedures
Antifibrinolytic Agents
Hemostasis
Adhesives
Hemorrhage
Pharmaceutical Preparations
Population

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Improving outcomes through the use of surgical sealants for anastomotic sealing during cardiovascular surgery : Review articles. / DeAnda, Abelardo; Elefteriades, John A.; Hasaniya, Nahidh W.; Lattouf, Omar M.; Lazzara, Robert R.

In: Journal of Cardiac Surgery, Vol. 24, No. 3, 05.2009, p. 325-333.

Research output: Contribution to journalArticle

DeAnda, Abelardo ; Elefteriades, John A. ; Hasaniya, Nahidh W. ; Lattouf, Omar M. ; Lazzara, Robert R. / Improving outcomes through the use of surgical sealants for anastomotic sealing during cardiovascular surgery : Review articles. In: Journal of Cardiac Surgery. 2009 ; Vol. 24, No. 3. pp. 325-333.
@article{b7aa7e8b97b3435ab8682db9d056c9a4,
title = "Improving outcomes through the use of surgical sealants for anastomotic sealing during cardiovascular surgery: Review articles",
abstract = "The continued need to minimize blood product usage both during and after cardiac surgical procedures has been challenged by a changing patient population, and most recently by the withdrawal of the antifibrinolytic aprotinin (Trasylol, Bayer Pharmaceuticals, West Haven, CT, USA) from the market. To meet these challenges, a variety of topical hemostatic tools have continued to emerge in the surgical armamentarium. These include hemostatic agents, adhesives, and sealants designed to control perioperative bleeding and decrease blood product utilization. Optimal application of novel topical adjuncts can be limited due to the lack of clarity on how to differentiate between these adjunctive hemostatic products and their appropriate uses. This paper will review the classes of these products, how and where such products can be used during cardiovascular surgery for achieving hemostasis, and the potential for improved outcomes through the appropriate selection and use of these agents.",
author = "Abelardo DeAnda and Elefteriades, {John A.} and Hasaniya, {Nahidh W.} and Lattouf, {Omar M.} and Lazzara, {Robert R.}",
year = "2009",
month = "5",
doi = "10.1111/j.1540-8191.2009.00809.x",
language = "English (US)",
volume = "24",
pages = "325--333",
journal = "Journal of Cardiac Surgery",
issn = "0886-0440",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Improving outcomes through the use of surgical sealants for anastomotic sealing during cardiovascular surgery

T2 - Review articles

AU - DeAnda, Abelardo

AU - Elefteriades, John A.

AU - Hasaniya, Nahidh W.

AU - Lattouf, Omar M.

AU - Lazzara, Robert R.

PY - 2009/5

Y1 - 2009/5

N2 - The continued need to minimize blood product usage both during and after cardiac surgical procedures has been challenged by a changing patient population, and most recently by the withdrawal of the antifibrinolytic aprotinin (Trasylol, Bayer Pharmaceuticals, West Haven, CT, USA) from the market. To meet these challenges, a variety of topical hemostatic tools have continued to emerge in the surgical armamentarium. These include hemostatic agents, adhesives, and sealants designed to control perioperative bleeding and decrease blood product utilization. Optimal application of novel topical adjuncts can be limited due to the lack of clarity on how to differentiate between these adjunctive hemostatic products and their appropriate uses. This paper will review the classes of these products, how and where such products can be used during cardiovascular surgery for achieving hemostasis, and the potential for improved outcomes through the appropriate selection and use of these agents.

AB - The continued need to minimize blood product usage both during and after cardiac surgical procedures has been challenged by a changing patient population, and most recently by the withdrawal of the antifibrinolytic aprotinin (Trasylol, Bayer Pharmaceuticals, West Haven, CT, USA) from the market. To meet these challenges, a variety of topical hemostatic tools have continued to emerge in the surgical armamentarium. These include hemostatic agents, adhesives, and sealants designed to control perioperative bleeding and decrease blood product utilization. Optimal application of novel topical adjuncts can be limited due to the lack of clarity on how to differentiate between these adjunctive hemostatic products and their appropriate uses. This paper will review the classes of these products, how and where such products can be used during cardiovascular surgery for achieving hemostasis, and the potential for improved outcomes through the appropriate selection and use of these agents.

UR - http://www.scopus.com/inward/record.url?scp=67651180921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651180921&partnerID=8YFLogxK

U2 - 10.1111/j.1540-8191.2009.00809.x

DO - 10.1111/j.1540-8191.2009.00809.x

M3 - Article

C2 - 19438792

AN - SCOPUS:67651180921

VL - 24

SP - 325

EP - 333

JO - Journal of Cardiac Surgery

JF - Journal of Cardiac Surgery

SN - 0886-0440

IS - 3

ER -